Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: A randomized trial

Essam, Hatem; Wahab, Nashwa Hassan Abdel; Younis, Gihan; Elsayed, Enas; Shafiek, Hanaa

doi:10.1371/journal.pone.0268589

Cited by 7 publications

(3 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pulmonary symptom scores in our study using the CAT demonstrated a statistically significant reduction during the course of the study, which was consistent with prior studies that have demonstrated that pulmonary exercises are effective in improving quality of life and pulmonary symptom scores in patients with COPD, asthma, bronchiectasis, and restrictive lung diseases (Essam et al, 2022;Pehlivan et al, 2019;Renolleau-Courtois et al, 2014;Tarigan et al, 2020). Recently, a 5-week, randomized controlled study of 52 individuals with post-COVID-19-related dyspnea who received a respiratory exercise breathing program via tele-medicine reported significantly improved quality of life scores in those individuals who were in the intervention group (Okan et al, 2022).…”

Section: Discussionsupporting

confidence: 91%

Home-Based Pilot Pulmonary Program for Dyspneic Patients Post-COVID-19

et al. 2023

View full text Add to dashboard Cite

It is estimated that at least 10% of people who have had COVID-19 will experience ongoing symptoms such as shortness of breath, fatigue, and cognitive disturbances. Pulmonary exercise has demonstrated improved dyspnea outcomes in other respiratory conditions. Thus, the purpose of this study was to assess the efficacy of a home-based pulmonary rehabilitation program in post-COVID-19 survivors who continue to experience dyspnea. This was a longitudinal, single group pilot study in which 19 patients received a home-based expiratory muscle strength training program over 12 weeks. Outcomes measured at baseline, 6 weeks, and 12 weeks included pulmonary symptoms, functional performance, thoracic expansion, forced expiratory volume, and expiratory resistance measures. Significant improvements were found in pulmonary symptoms ( p < .001), functional performance ( p = .014), and progressive expiratory resistance capabilities ( p < .001). A home-based pulmonary program may be an inexpensive strategy for post-COVID-19 survivors who continue to experience dyspnea.

show abstract

Section: Discussionsupporting

confidence: 91%

Home-Based Pilot Pulmonary Program for Dyspneic Patients Post-COVID-19

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In this study, participants walked 119 m further ( p < .001), and the pulmonary symptom scores decreased by 7.3 points ( p < .001) following the pulmonary rehabilitation intervention (Hockele et al, 2022). Other studies have also resported signficant improvements in exercise capacity as pulmonary symptoms decrease, following respiratory strengthening interventions in both obstructive and restrictive lung disease populations (Essam et al, 2022; Lu et al, 2020; Mota et al, 2007). Thus, as participant’s pulmonary symptoms decrease following a respiratory strengthening intervention, exercise capacity tends to improve.…”

Section: Discussionmentioning

confidence: 93%

Body Mass Index and Thoracic Expansion in Post-COVID Dyspnea: A Secondary Analysis

Morgan,

Thomas,

Morris

et al. 2024

Clin Nurs Res

View full text Add to dashboard Cite

Dyspnea secondary to lung impairment can persist following the acute phase of COVID-19. Thoracic expansion measurements have been used as a diagnostic tool to evaluate chest wall mobility, respiratory function, and the effects of respiratory muscle strength training. Changes in chest wall mobility may occur because of altered chest biomechanics in individuals with respiratory diseases and an elevated body mass index (BMI). The purpose of this secondary analysis was to evaluate whether BMI influences thoracic expansion or forced expiratory volume over 1 second (FEV1) in individuals with persistent dyspnea following COVID-19. This study assessed the relationship between BMI and thoracic expansion, pulmonary symptoms, and exercise capacity following a home-based pulmonary rehabilitation intervention. A secondary data analysis was conducted with a sample of 19 adults with persistent dyspnea following COVID-19 infection who participated in a 12-week, home-based pulmonary rehabilitation study. Participants received expiratory muscle strength training devices and were instructed to perform pulmonary rehabilitation exercises three times per week over the study period. Pulmonary function, pulmonary symptoms, exercise capacity, and BMI measurements were collected. For analysis, study participants were divided into obese (BMI > 30 kg/m2) or nonobese (BMI < 30 kg/m2) categories. Correlations using the change scores from baseline to 12 weeks between thoracic expansion, FEV1, pulmonary symptoms, and exercise capacity were assessed. In addition, the minimal detectable change (MDC) in thoracic expansion was explored. Thoracic expansion was significantly improved after 12 weeks of training ( p = .012) in the nonobese group. There was a significant correlation between the change in walking distance and pulmonary symptoms ( r = −.738, p < .001) and in thoracic expansion ( r = .544, p = .020), and walking distance, when controlling for BMI, but no change in FEV1. Average MDC was 1.28 for inspiration and 0.91 for expiration. Measurements of thoracic expansion were significantly lower in post-COVID individuals with an increased BMI. Individuals with persistent dyspnea and a higher BMI may require additional measures to increase chest mobility or to detect pulmonary changes following COVID-19.

show abstract

“…On the other hand, Gloeckl et al proved that SF-36 mental components were significantly improved [36]. Improvements in QOL can be attributed to exercise-based pulmonary rehabilitation programs and its benefits, breathing control due to breathing, exercises, and overall fitness and wellness [48][49][50].…”

Section: Discussionmentioning

confidence: 99%

Effect of Home-Based Pulmonary Rehabilitation on Pulmonary Fibrosis

Saha,

Singh,

Samuel

et al. 2024

Multidisciplinary Respiratory Medicine

View full text Add to dashboard Cite

Background: Pulmonary fibrosis is a chronic, progressive lung condition that involves lung tissue scarring and thickening. The effects of home-based pulmonary rehabilitation (PR) in post-covid pulmonary fibrosis (PCPF) and other forms of fibrosis together have not been evaluated. This study aims to evaluate the effectiveness of home-based pulmonary rehabilitation on pulmonary function, functional capacity, and health-related quality of life in people with pulmonary fibrosis (post-COVID pulmonary fibrosis, pulmonary fibrosis secondary to pulmonary tuberculosis (TB), pulmonary fibrosis secondary to interstitial lung disease (ILD), pulmonary fibrosis secondary to bronchiectasis). Methods: A single-group pretest–posttest experimental study was performed after recruiting 98 pulmonary fibrosis subjects from K.M.C hospitals. After being screened for the inclusion and exclusion criteria, 45 subjects were analyzed, and 6 subjects were lost to follow-up. A home-based pulmonary rehabilitation program was carried out for 8 weeks (warm-up, stretching exercises, aerobic exercise, strength training for upper limb and lower limb, breathing exercises mainly involved; others: energy saving techniques, controlled coughing techniques, dyspnea relieving positions). The program was supervised via weekly phone calls. Pulmonary function (Pulmonary function test), exercise capacity (6-minute walk test), dyspnea (modified Borg scale), and health-related quality of life (SF-36) were evaluated before and after the intervention. During the enrollment and after the 6-minute walk test, saturation of peripheral oxygen (SPO2) level was also evaluated pre-intervention and after the 8-weeks program. Results: Pulmonary function [FVC(L) t = -12.52, p<0.05; FEV1(L) t = -2.56, p<0.05; FEV1/FVC t = 7.98, p<0.05 and DLCO (ml/min/mmHg) t = -5.13, p<0.05], 6MWD [MD 88.66; p<0.05] and HRQOL measured by SF-36 scores (p<0.05) were improved significantly. Both the baseline SPO2 level before the 6MWT [MD 1.07, p<0.05] and the SPO2 level after the 6MWT [MD 1.16, p<0.05] showed a significant improvement. The rating of perceived exertion(dyspnea) [MD 1.30, p<0.05] was reduced significantly after the 8-week program. Conclusion: Our study shows that home-based pulmonary rehabilitation is an effective option for improving lung function and physical functional capacity by reducing dyspnea perception and improving the saturation of peripheral oxygen (SPO2) level, and enhancing the quality of life in people with pulmonary fibrosis.

show abstract

Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: A randomized trial

Cited by 7 publications

References 44 publications

Home-Based Pilot Pulmonary Program for Dyspneic Patients Post-COVID-19

Home-Based Pilot Pulmonary Program for Dyspneic Patients Post-COVID-19

Body Mass Index and Thoracic Expansion in Post-COVID Dyspnea: A Secondary Analysis

Effect of Home-Based Pulmonary Rehabilitation on Pulmonary Fibrosis

Contact Info

Product

Resources

About